Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 17 Neoplasms 5 Neoplasm Metastasis 5 Colonic Neoplasms 4 Stomach Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Rectal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unresectable Metastatic Colorectal Cancer 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastroesophageal Adenocarcinoma 1

Interventions

pembrolizumab 11 Injections 10 tislelizumab 7 Nivolumab 4 Irinotecan 4 Cetuximab 4 cediranib 3 Paclitaxel 3 PM 01183 3 Leucovorin 3 Gemcitabine 3 Fluorouracil 3 Cisplatin 3 toripalimab 2 spartalizumab 2 serabelisib 2 olaparib 2 glumetinib 2 camrelizumab 2 apatinib 2 adagrasib 2 Therapeutics 2 Pemetrexed 2 Oxaliplatin 2 Midazolam 2 Drug Therapy 2 Docetaxel 2 Digoxin 2 Cyclophosphamide 2 Carboplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumor × IFL protocol × Clear all

NCT05147350 2025-12-05

MINOTAUR

Debiopharm International SA

Phase 1 Terminated

38 enrolled 17 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡